A Look At Línea Directa (BME:LDA) Valuation After Higher Full Year Net Income Figures

Línea Directa Aseguradora Compañía de Seguros y Reaseguros (BME:LDA) recently reported fourth quarter net income of €26.04 million and full year 2025 net income of €85.71 million, drawing fresh attention to the stock.

See our latest analysis for Línea Directa Aseguradora Compañía de Seguros y Reaseguros.

Despite the latest earnings drawing attention, the current share price of €1.178 comes after a 9.25% 7 day share price decline. However, the 90 day share price return of 7.09% and 3 year total shareholder return of 34.15% suggest longer term momentum has been stronger than the recent setback.

If these earnings have you reassessing the insurance space, it could be worth widening your search with our screener of 96 top founder-led companies to spot other potential ideas.

With net income at €85.71 million, a share price of €1.178 and indications of an intrinsic discount and analyst upside, the key question is simple: Is Línea Directa a value opportunity, or is the market already pricing in future growth?

Price-to-Earnings of 15x: Is it justified?

Línea Directa is trading on a P/E of 15x, which current data suggests is expensive compared with several reference points, even after the recent share price pullback to €1.178.

The P/E multiple compares the share price to earnings per share and is a common way investors gauge how much they are paying for each unit of current earnings. For an insurer like Línea Directa, this helps you see whether the market is attaching a premium or discount compared with similar companies.

Here, the picture is clear. The company is described as expensive versus its peer group average P/E of 11x, and also versus the wider European insurance industry average of 13x. In addition, our fair-value regression suggests a P/E of 12.6x would be more aligned with fundamentals, so the current 15x points to a richer valuation level that the market could adjust toward if sentiment or expectations change.

Explore the SWS fair ratio for Línea Directa Aseguradora Compañía de Seguros y Reaseguros

Result: Price-to-Earnings of 15x (OVERVALUED)

However, you still need to weigh risks such as a potential de-rating toward peer P/E levels and any shift in analyst targets that reduces the current discount.

Find out about the key risks to this Línea Directa Aseguradora Compañía de Seguros y Reaseguros narrative.

Another view: DCF points the other way

While the 15x P/E suggests Línea Directa looks expensive, our DCF model suggests otherwise. It estimates the future cash flow value at €2.09 per share compared with the current €1.18 price, indicating that the shares trade at a discount that the P/E alone does not capture.

Look into how the SWS DCF model arrives at its fair value.

Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out Línea Directa Aseguradora Compañía de Seguros y Reaseguros for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 231 high quality undervalued stocks. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity.

Next Steps

If this mix of signals leaves you on the fence, now is a good time to review the underlying data yourself and weigh up 3 key rewards and 1 important warning sign.

Looking for more investment ideas?

If this has sharpened your interest in valuations and risks, do not stop here. Broaden your watchlist and benchmark Línea Directa against other opportunities.

• Target quality at a discount by scanning our list of 231 high quality undervalued stocks that combine solid fundamentals with prices that may sit below their calculated worth.
• Build your income stream by reviewing 455 dividend fortresses, a focused set of higher yielding companies for investors who care about getting paid regularly.
• Reduce portfolio stress by filtering for resilience using our 304 resilient stocks with low risk scores, highlighting companies with more robust risk profiles.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com